OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Optimizing these processes involves adjusting various factors, including cell line selection, media formulation, and bioreactor conditions. A key goal is to amplify antibody production while lowering production financ